Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024

Date: April 1, 2019
Pages: 133
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C43738E94D3EN
Leaflet:

Download PDF Leaflet

Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024
“Cell-based assays market to register a CAGR of 6.3% from 2019 to 2024”

The cell-based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing research funding, and the growth in the number of drug discovery activities. Emerging economies with growing R&D expenditures are also expected to provide opportunities for the growth of the market.

“Services exhibited the highest CAGR over the forecast period.”

By product & service, the cell-based assays market is segmented into consumables, instruments and services. Over the forecast period, the services segment accounted for the highest CAGR. The increased R&D investments and technological innovations in supportive processes such as high-throughput screening is driving the growth of this product & service segment.

“Basic research held the significant share in the cell-based assays market in 2019”

On the basis of application, the cell-based assays market is segmented into drug discovery, basic research and other research such as quality check among others. In 2019, the drug discovery segment accounted for the largest share of the cell-based assays market. The large share of this segment can be attributed to the rising adoption of in vitro testing over animal testing and increasing in R&D spending by biopharmaceutical companies.

“Asia Pacific exhibited the highest CAGR over the forecast period”

North America, which includes the US and Canada, accounted for the largest share of the cell-based assays market. The large share of this market segment can be attributed to the increasing drug discovery activities by pharmaceutical and biotechnology companies. In addition to this, consolidations between academic and government institutes with biopharmaceutical companies in the region are also driving the growth of this market.

Breakdown of supply-side primary interviews, by company type, designation, and region:
  • By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), Asia Pacific (25%), and RoW (16%)
Some of the major players in this market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US).

Research Coverage

This report studies the cell-based assays market based on products, applications, end users, and regions. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell-based assays market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the cell-based assays offered by the top 10 players in the cell-based assays market. The report analyzes the cell-based assays market by product, , end user, application, and region
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various cell-based assays across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-based assays market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell-based assays market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
  1.2.1 MARKETS COVERED
  1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  2.1.1 SECONDARY DATA
    2.1.1.1 Key Data from Secondary Sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
  2.2.1 BOTTOM-UP APPROACH
  2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 CELL-BASED ASSAYS: MARKET OVERVIEW
4.2 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE AND APPLICATION (2018)
4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL-BASED ASSAYS MARKET

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 DRIVERS
    5.2.1.1 Growing preference for cell-based assays
    5.2.1.2 Growing research funding
    5.2.1.3 Growth in the number of drug discovery activities
  5.2.2 RESTRAINT
    5.2.2.1 High cost of instruments and restrictions on reagent use
  5.2.3 OPPORTUNITIES
    5.2.3.1 High-growth Asian countries
    5.2.3.2 Application of novel cell-based assays in cancer research

6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE

6.1 INTRODUCTION
6.2 CONSUMABLES
  6.2.1 REAGENTS
    6.2.1.1 Reagents have widespread usage in life sciences due to their application in immunology research, disease research, and cancer diagnostics
  6.2.2 ASSAY KITS
    6.2.2.1 Reporter gene assays
      6.2.2.1.1 Reporter gene assays can be used with limited resources for the establishment of HTS platforms, presenting opportunities for small laboratories with limited resources
    6.2.2.2 Second messenger assays
      6.2.2.2.1 Second messenger assays allow the detection and characterization of all compound classes—a key driver for market growth
    6.2.2.3 Cell growth assays
      6.2.2.3.1 Cell viability and cell proliferation assays are the two most important in vitro quantification techniques for assessing cell growth
    6.2.2.4 Cell death assays
      6.2.2.4.1 Cell death quantification is essential in drug development to identify the manner in which potential drugs could inhibit or enhance molecular targets—a key factor propelling market demand
    6.2.2.5 Other assay kits
  6.2.3 PROBES & LABELS
    6.2.3.1 Effective labeling of cells helps in studying cellular events in a spatial and temporal context—a key factor driving the demand for probes and labels
  6.2.4 MICROPLATES
    6.2.4.1 Increasing demand for cell-based assays in drug discovery, basic research, and preclinical safety studies is encouraging the consumption of microplates
  6.2.5 CELL LINES
    6.2.5.1 Immortalized cell lines
      6.2.5.1.1 Advantages of immortalized cell lines creating a demand for these cell lines over primary and stem cell lines
    6.2.5.2 Primary cell lines
      6.2.5.2.1 Primary cell lines are more sensitive as compared to immortalized cell lines—a key factor limiting market growth
    6.2.5.3 Stem cell lines
      6.2.5.3.1 Stem cell lines are alternative methodologies to address the cellularity issues that involve the directed differentiation of embryonic stem (ES) cells or induced pluripotent stem cells (iPS)
  6.2.6 OTHER CONSUMABLES
6.3 INSTRUMENTS
  6.3.1 BIOTECHNOLOGY COMPANIES AIM TO STREAMLINE THEIR WORKFLOWS TO IMPROVE PRODUCTIVITY AND REDUCE COSTS, WHICH WILL DRIVE THE GROWTH OF THE INSTRUMENTS MARKET
6.4 SERVICES

7 CELL-BASED ASSAYS MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 DRUG DISCOVERY
  7.2.1 TOXICITY STUDIES
    7.2.1.1 Increasing adoption of high-content screening for evaluating cytotoxicity is a factor stimulating the use of cell-based assays for toxicity studies
  7.2.2 PHARMACOKINETIC STUDIES
    7.2.2.1 Demand for ADME studies to rise due to the growing need for improved clinical success—a major factor driving growth
  7.2.3 PHARMACODYNAMIC STUDIES
    7.2.3.1 Increasing number of pharmacodynamics studies globally to drive growth in the cell-based assays market
7.3 BASIC RESEARCH
  7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE THE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
7.4 OTHER APPLICATIONS

8 CELL-BASED ASSAYS MARKET, BY END USER

8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  8.2.1 THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT IS PRIMARILY DRIVEN BY THE GROWTH IN THE NUMBER OF R&D ACTIVITIES
8.3 ACADEMIC & GOVERNMENT INSTITUTES
  8.3.1 INCREASING INTEREST OF ACADEMIC INSTITUTIONS TO DEVELOP ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT
8.4 CONTRACT RESEARCH ORGANIZATIONS
  8.4.1 GROWTH IN OUTSOURCING TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS

9 CELL-BASED ASSAYS MARKET, BY REGION

9.1 INTRODUCTION
9.2 NORTH AMERICA
  9.2.1 US
  9.2.2 CANADA
9.3 EUROPE
  9.3.1 UK
  9.3.2 GERMANY
  9.3.3 FRANCE
  9.3.4 REST OF EUROPE
9.4 ASIA PACIFIC
  9.4.1 CHINA
  9.4.2 JAPAN
  9.4.3 INDIA
  9.4.4 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 MARKET RANKING ANALYSIS, 2017
  10.2.1 CELL-BASED ASSAYS MARKET RANKING, BY KEY PLAYER, 2017
10.3 KEY STRATEGIES
  10.3.1 PRODUCT LAUNCHES, 2015–2018
  10.3.2 EXPANSIONS, 2015–2018
  10.3.3 COLLABORATIONS, 2015–2018:
  10.3.4 ACQUISITIONS, 2015–2018
10.4 COMPETITIVE LEADERSHIP MAPPING (2017)
10.5 VISIONARY LEADERS
10.6 INNOVATORS
  10.6.1 DYNAMIC DIFFERENTIATORS
  10.6.2 EMERGING COMPANIES
10.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017)
  10.7.1 PROGRESSIVE COMPANIES
  10.7.2 STARTING BLOCKS
  10.7.3 RESPONSIVE COMPANIES
  10.7.4 DYNAMIC COMPANIES

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 THERMO FISHER SCIENTIFIC INC.
11.2 DANAHER CORPORATION
11.3 BECTON, DICKINSON AND COMPANY
11.4 GE HEALTHCARE
11.5 MERCK KGAA
11.6 LONZA GROUP LTD.
11.7 PERKINELMER, INC.
11.8 CHARLES RIVER LABORATORIES, INC.
11.9 CELL SIGNALING TECHNOLOGY, INC.
11.10 PROMEGA CORPORATION
11.11 CISBIO
11.12 CELL BIOLABS, INC.
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 CELL-BASED ASSAYS MARKET: BOTTOM-UP APPROACH
FIGURE 4 CELL-BASED ASSAYS MARKET: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
FIGURE 7 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 8 CELL-BASED ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 9 CELL-BASED ASSAYS MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
FIGURE 10 GROWTH IN THE NUMBER OF DRUG DISCOVERY ACTIVITIES IS DRIVING THE DEMAND FOR CELL-BASED ASSAYS
FIGURE 11 DRUG DISCOVERY APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF
THE CELL-BASED ASSAYS MARKET IN 2018
FIGURE 12 COUNTRIES IN APAC TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD
FIGURE 13 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 14 CONSUMABLES TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING
THE FORECAST PERIOD
FIGURE 15 DRUG DISCOVERY APPLICATIONS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ESTIMATED TO BE THE LARGEST END USERS OF CELL-BASED ASSAYS DURING THE FORECAST PERIOD
FIGURE 17 NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET
FIGURE 18 NORTH AMERICA: CELL-BASED ASSAY MARKET SNAPSHOT
FIGURE 19 APAC: CELL-BASED ASSAYS MARKET SNAPSHOT
FIGURE 20 KEY DEVELOPMENTS IN THE CELL-BASED ASSAYS MARKET FROM 2015 TO 2019
FIGURE 21 MNM DIVE-VENDOR COMPARISON MATRIX: CELL-BASED ASSAYS MARKET
FIGURE 22 MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: CELL-BASED
ASSAYS MARKET
FIGURE 23 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2017)
FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 25 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
FIGURE 26 GE HEALTHCARE: COMPANY SNAPSHOT (2018)
FIGURE 27 MERCK KGAA: COMPANY SNAPSHOT (2017)
FIGURE 28 LONZA GROUP LTD.: COMPANY SNAPSHOT (2017)
FIGURE 29 PERKINELMER, INC.: COMPANY SNAPSHOT (2018)
FIGURE 30 CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2017)

The bottom-up approach was implemented for arriving at the overall market size of the cell-based  assays  market,  based  on  the  market  size  of  major  product  submarkets  such  as consumables,  instruments,  software,  and  services.  Similarly  the  overall  consumables  and instruments  market  was  derived  by  summing  up  the  market  sizes  of  different  types  of consumables  and  instruments.  Further,  the  total  software  and  services  market  (which  was validated using the top-down approach) was added to the total consumables and instruments market to derive the overall market size of cell-based assays market.

This overall market size was used in the top-down procedure to estimate the market sizes of all other individual market segments and subsegments by product, application, end user, and geography using percentage splits from secondary and primary research. The market sizes of different products submarkets obtained by the bottom-up approach were validated by the top-down approach. Thus, using a combination of top-down and bottom-up approaches, the overall cell-based assay market size was arrived at.

Cell-based assays have an edge over in vitro biochemical assays in several aspects. Cell-based assays are believed to provide more precise, tissue-specific responses in a biologically relevant microenvironment, in comparison with biochemical assays. The drug responses in biochemical assays may not resemble the drug responses in a cellular context. Moreover, it is not possible to  prepare  or  purify  every  target  for  biochemical  measurement,  thereby  restricting  the applications  of  biochemical  assays.  Owing  to  this,  pharmaceutical  and  biotechnology companies  are  eventually  replacing  biochemical  assays  with  cell-based  assays  in  lead identification and optimization processes of drug discovery. 

Although cell-based assays cannot fully replace animal testing, early phase toxicity screening has been definitely considered to be in the realm of cell-based assays. Conventional methods of  toxicity  and  drug  safety  assessment  involved  animal  testing  which  is  expensive,  time-consuming,  and  low-throughput.  Additionally,  animal  model  studies  are  faced  with  ethical issues, lack of interaction mechanism, and often fail to extrapolate to human drug responses.

Cell-based  assays  enable  relatively  inexpensive  cytotoxicity  studies  which  provide  an  early evidence of toxicity attributes of a potential drug candidate. Recent efforts are directed toward reducing the number of animal tests using high throughput cell-based assays which not only increase drug screening efficiency but also fasten the drug discovery process.

Thus, cell-based assays present a preferable alternative for biochemical assays and animals as a result of their physiological relevance, inherent virtues, and ability to provide efficient, cost-effective, and accelerated drug discovery solutions.

The material was prepared in June, 2014.

LIST OF TABLES

TABLE 1 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 2 CELL-BASED CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 3 CELL-BASED CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 CELL-BASED REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 5 CELL-BASED ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 6 CELL-BASED ASSAY KITS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 7 REPORTER GENE ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 8 SECOND MESSENGER ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 CELL GROWTH ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 10 CELL DEATH ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 OTHER ASSAY KITS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 12 CELL-BASED PROBES & LABELS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 CELL-BASED MICROPLATES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 CELL LINES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 15 CELL LINES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 16 IMMORTALIZED CELL LINES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 PRIMARY CELL LINES MARKET FOR, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 STEM CELL LINES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 OTHER CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 20 CELL-BASED INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 21 CELL-BASED ASSAY SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 22 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 23 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY TYPE, 2017–2024 (USD MILLION)
TABLE 25 CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 26 CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 27 CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 28 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2017–2024 (USD MILLION)
TABLE 29 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 30 CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 31 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 32 CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2017–2024 (USD MILLION)
TABLE 33 CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 34 CELL-BASED ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 35 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 36 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017–2024 (USD MILLION)
TABLE 37 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 38 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 39 US: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017–2024 (USD MILLION)
TABLE 40 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 41 US: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 42 CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017–2024 (USD MILLION)
TABLE 43 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 44 CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 45 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46 EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERIVECS, 2017–2024 (USD MILLION)
TABLE 47 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 48 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 49 UK: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017–2024 (USD MILLION)
TABLE 50 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 51 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 52 GERMANY: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017–2024 (USD MILLION)
TABLE 53 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 54 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 55 FRANCE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 56 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 57 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 58 ROE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 59 ROE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 60 ROE: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 61 APAC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 62 APAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 63 APAC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 64 APAC: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 65 CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 66 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 67 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 68 JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 69 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 70 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 71 INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 72 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 73 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 74 ROAPAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 75 ROAPAC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 76 ROAPAC: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 77 ROW: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 78 ROW: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 79 ROW: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)

Skip to top


Ask Your Question

Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: